Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (62)

Latest Posts

About This Stock More About This Stock
Allergan Says Study Of Higher Doses Of BOTOX Meets Primary Endpoint
Article By: The Fly
Friday, September 14, 2018 8:09 PM EDT
Allergan announced clinical study results of higher doses of BOTOX Cosmetic compared to BOTOX Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines.
In this article: AGN
Read
Allergan Upgraded To Buy From Neutral At Mizuho
Article By: The Fly
Friday, August 3, 2018 9:31 AM EDT
Mizuho analyst Irina Koffler upgraded Allergan to Buy and raised her price target for the shares to $210 from $194.
In this article: AGN
Read
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research
Friday, May 4, 2018 8:15 PM EDT
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
Read
Allergan Beats Q1 Earnings, Stock Up
Article By: Zacks Investment Research
Monday, April 30, 2018 12:09 PM EDT
Allergan’s first-quarter earnings of $3.74 per share were above our consensus estimate of $3.36 per share.
In this article: AGN
Read
Should You Buy Allergan Plc When Prices Drop?
Article By: Matthew Hogan
Wednesday, April 4, 2018 4:37 PM EDT
Allergan plc investors have enjoyed seeing the stock price increase by 16.9% over the last month.
In this article: AGN
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Patent Losses Could Sink Allergan
Dean Gilmore 2/5/2018 2:37:30 PM

Look at where $AGN was a year ago. It has lost a chunk of it's value already. This news won't help.

Patent Losses Could Sink Allergan
Alpha Stockman 2/5/2018 2:26:42 PM

These hits all hurt #Allergan's bottom line but aren't it's cash cows like #Botox which still does very well for the company and will only only generate even more revenue over time. $AGN

Patent Losses Could Sink Allergan
Ayelet Wolf 2/5/2018 2:22:51 PM

This news sounds catastrophic to me. Why isn't #Allergan tanking? $AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 4 of 4 comments